1[1]Zhou F, Huang L. Monophosphoryl lipid A enhances specific CTL in-duction by a soluble protein antigen entrapped in liposomes[J]. Vac-cine, 1993,11:1139
2[2]Goyal K, Human L. Gene therapy using DC-Chol cationic liposomes[J]. Liposome Res, 1994,4:1075
3[3]Brunel F, Darbouret A. Cationic lipid DC-Chol induces an improvedand balanced immunity able to overcome the unresponsiveness to thehepatitis B vaccine[J]. Vaccine, 1999,17:2192
4[4]Gao X, Huang L.A novel cationic liposome reagent for efficient tranfec-tion of mammalian cells[ J]. Biochem Biophys Res Commun, 1991,179: 280
5[5]Shahum E, Therien HM. Immunopotentiation of the humoral responseby liposomes:encapsulation versus covalent linkage[J]. Immunology,1998,65:315
6[6]Choi JS, Lee EJ. New cationic liposomes for gene transfer into mam-malian cells with high efficiency and low toxicity[J]. Bioconjug chem,2001,12:108
7[7]Guy B, Pascal N. Design, chatacterization and preclinical efficacy of acationic lipid adjuvant for influenza split vaccine[ J]. Vaccine, 2001,19:1794
8Liu JL, Fontaine J, Capron A, et al. Uttrastructural localization of Sm28GST protective antigen in Schistosoma mansoni adult worms[J]. Parasitology, 1996,113(Pt 4):377-391.
9Hornung V, Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides [J]. J Immunol, 2002, 168(9):4531-4537.
10Dalpke AH, Zimmermann S, Albrecht I, et al. Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo [J]. Immunology, 2002, 106(1):102-112.
